Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme
Related Posts
Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]
Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]
Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra[...]